Home Finance Instil Bio Puts AstraZeneca-Leased 128,000 SQFT Tarzana Cell Therapy Plant on the Market, Offers Due Nov. 17
FinanceIndustrialIndustry NewsLife ScienceLos Angeles

Instil Bio Puts AstraZeneca-Leased 128,000 SQFT Tarzana Cell Therapy Plant on the Market, Offers Due Nov. 17

Share
trnava-university-Ao6MBMOB8Po-unsplash-lab
Photo by Trnava University on Unsplash
Share

Instil Bio has put its 128,097-square-foot Tarzana cell therapy plant back on the block with JLL and set a Nov. 17 call for offers, testing how much investors will pay for a nearly new cGMP facility leased to AstraZeneca through 2039 that its owner built for roughly $172 million.

Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.

Share

Featured Content


Recent Posts

Related Articles

Smoky Hollow Industries Pays SATCO $34.3MM for 79,000 SQFT El Segundo Industrial/Flex Campus

A local developer entity that has spent years converting El Segundo's old...

150-Bed Co/Relate West Adams Co-Living Property Hits Market in Los Angeles With $34MM Condo Sellout Pitch

Co/Relate West Adams, a 2023-built co-living community of 30 five-bedroom townhomes on...

143,000 SQFT 30 Enterprise Hits Aliso Viejo Market as Owner-User Play Ahead of Otsuka’s 2027 Exit

A renovated, four-story Class A office building on Aliso Viejo's Summit Office...